|

KK-LC-1 TCR-T cells Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Adoptive cell transfer, CAR-T, KK-LC-1 TCR, TCR, TIL

Pipeline

Phase 1: 1

Top Sponsors

  • Christian Hinrichs1

Indications

  • Gastric Cancer1
  • Cervical Cancer1
  • Lung Cancer1
  • Breast Cancer1
  • Cancer1

New Brunswick, New Jersey1 trial

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

Rutgers Cancer Institute of New Jersey

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.